STX2 and infection: In summary, we demonstrated that O‐GlcNAc inhibition improves mortality and various disease symptoms caused by Stx2a exposure in mice, further reinforcing O‐GlcNAc inhibition as a novel strategy for the development of new agents to treat life‐threatening complications which may occur following infection with Stx‐producing bacteria.